Pacific Biomarkers (OTC BB:PBMC)

"We expect to look back upon Fiscal 2009 as a year during which we

(1) substantially strengthened our balance sheet by paying off all long- and short-term debt; (2) recorded an impressive earnings turnaround
(3) bolstered our competitive position in our core areas of cardiovascular disease, diabetes, metabolic syndrome, osteoporosis and arthritis
(4) positioned the Company for growth opportunities in the multi-billion-dollar biomarker services industry.

These are exciting times for Pacific Biometrics, and while our quarterly results can fluctuate due to the timing of order receipts and contract performance, we are very optimistic regarding prospects for the Company in the years ahead," concluded Helm.

Source: Marketwire (May 18, 2009)